GCL SI Makes Waves at COP28, Showcasing Strong Commitment to Triple Renewable Energy Capacity
DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ — The critical 28th United Nations Climate Change Conference, or Conference of Parties (COP28) is currently taking place in Dubai, bringing together global leaders and companies to take decisive action against climate change. As a leading renewable energ
Sustainability Empowerment, Brand Upgrade VIVOTEK among Taiwan’s Best Global Brands
TAIPEI, Dec. 11, 2023 /PRNewswire/ — VIVOTEK (3454TW), the global leading IP surveillance solution provider, has been selected to the Best Taiwan Global Brands, and consistently earned market recognition. The three development engines of operational excellence, comprehensive brand management,
China Shenhua Included in the List of 2023 Corporate Governance Best Practice Cases
BEIJING, Dec. 11, 2023 /PRNewswire/ — China Shenhua was recently selected as one of the 2023 Corporate Governance Best Practice Cases by the China Association for Public Companies and included in the China Listed Company Governance Report. China Shenhua attaches great importance to corporate g
Dr. Enherya Introduces JOY Ergonomix2, Elevating Breast Augmentation Standards in Taiwan and Hong Kong
TAIPEI, Dec. 11, 2023 /PRNewswire/ — October marked a notable milestone in Taiwan’s beauty industry as leading medical aesthetics group Dr. Enherya became the first on the island to embrace the advanced JOY Ergonomix2 technology, the latest evolution of the acclaimed JOY Magic Drop impla
Karyopharm Shares Data at ASH 2023 Showing Strong SVR and TSS Durability Observed from Phase 1 Study of Selinexor 60mg and Ruxolitinib in JAK Inhibitor (JAKi)-Naïve Myelofibrosis Patients, with no SVR or TSS Progressions Observed As of the Data Cutoff(1)
Biomarker Data from Phase 1 Study of Selinexor in Combination with Ruxolitinib in Treatment-Naïve Myelofibrosis (MF) Suggestive of Disease Modification Data Reinforce the Potential for Selinexor in Combination with Ruxolitinib to Become a Novel, First-Line Treatment for JAKi-Naïve Patients with M
Astellas’ VEOZA™ (fezolinetant) Approved by European Commission for Treatment of Vasomotor Symptoms Associated with Menopause
First-in-class treatment option reduces number and intensity of hot flashes and night sweats TOKYO, Dec. 10, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced the European Commission (EC) on December 7 approved VEO
Samyang Corporation, Expansion of global market by launching two new industrial water treatment equipment
Following ion exchange resin, RO membrane, and EDI have been released.Establishing three key materials for water treatmentBecoming a comprehensive solution provider through newly launched products and a new dedicated organization, “Water Solutions PU (Performance Unit)”. SEOUL, South Kor
Media Advisory – Prime Minister’s itinerary for Monday, December 11, 2023
OTTAWA, ON, Dec. 10, 2023 /CNW/ – Note: All times local National Capital Region, Canada Private meetings 5:00 p.m. The Prime Minister will deliver remarks at Hanukkah on the Hill. He will be joined by the Deputy Prime Minister and Minister of Finance, Chrystia Freeland, and the M
Media Advisory – Deputy Prime Minister’s itinerary for Monday, December 11, 2023
OTTAWA, ON, Dec. 10, 2023 /CNW/ – Note: All times local. Ottawa, Ontario Private meetings. 2:00 p.m. The Deputy Prime Minister will attend Question Period. This document is also available at https://deputypm.canada.ca/en SOURCE Deputy Prime Minister’s Office
SurplusGLOBAL Announces Participation in SEMICON JAPAN 2023 to Showcase the Legacy Parts Distribution Solutions
SEOUL, South Korea, Dec. 11, 2023 /PRNewswire/ — SurplusGLOBAL, a global leader in the legacy semiconductor equipment industry, has announced its participation in the SEMICON JAPAN 2023 exhibition. The event is scheduled to take place from December 13th to 15th, 2023, at the Tokyo Big Sight in
